G01N 33/5026
On cell morphology
Official title: {on cell morphology}
G01N33/5026 (On cell morphology) appears on 202 US grants and 332 published applications in this corpus.
Search patents in G01N- Granted patents
- 202
- Published applications
- 332
- Assignees
- 226
- Inventors
- 745
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 9 |
| 2003 | 3 | 7 |
| 2004 | 3 | 11 |
| 2005 | 0 | 7 |
| 2006 | 10 | 11 |
| 2007 | 2 | 15 |
| 2008 | 5 | 11 |
| 2009 | 5 | 17 |
| 2010 | 3 | 11 |
| 2011 | 6 | 7 |
| 2012 | 9 | 9 |
| 2013 | 6 | 13 |
| 2014 | 14 | 19 |
| 2015 | 11 | 27 |
| 2016 | 11 | 24 |
| 2017 | 10 | 18 |
| 2018 | 19 | 15 |
| 2019 | 12 | 10 |
| 2020 | 12 | 13 |
| 2021 | 12 | 20 |
| 2022 | 7 | 14 |
| 2023 | 6 | 8 |
| 2024 | 10 | 14 |
| 2025 | 8 | 10 |
| 2026 | 3 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Quantitative centrosomal amplification score to predict local recurrence of ductal carcinoma in situ9 Jun 2026US 12,650,430 B2Georgia State University Research Foundation, Inc.
- Methods and devices for live cell imaging analysis5 May 2026US 12,620,244 B2Nikon Corporation
- Methods for monitoring physiological status of a body organ24 Mar 2026US 12,584,904 B2BioCrine AB
- Cell evaluation method, cell evaluation device, and cell evaluation program30 Dec 2025US 12,511,736 B2Kyoto Prefectural Public University Corporation
- Systems and methods for discriminating effects on targets4 Nov 2025US 12,461,091 B2Recursion Pharmaceuticals, Inc.
- Methods of culturing cardiac cells and use of cells for disease modeling11 Jun 2026US 2026/0159815 A1Rambam Med-Tech Ltd.
- System and method for predictive modeling of cellular systems28 May 2026US 2026/0146990 A1George Mason University
- Cell Evaluation Method, Cell Evaluation Device, and Cell Evaluation Program28 May 2026US 2026/0148384 A1Kyoto Prefectural Public University Corporation
- Universal Efficient Dextran Microparticles Production with Microfluidic Technology12 Mar 2026US 2026/0071176 A1
- Production method of nerve cells damaged by oxidative stress and applications thereof12 Mar 2026US 2026/0071179 A1FUJIFILM Corporation
Most cited
By later US patents
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002
- Cardiac hypertrophy factor and uses therefor118US 5,534,615 AGenentech, Inc. · 1996
- System for cell-based screening96US 6,716,588 B2Cellomics, Inc. · 2004
- Engineered protein kinases which can utilize modified nucleotide triphosphate substrates92US 6,390,821 B1Princeton University · 2002
- Engineered protein kinases which can utilize nucleotide triphosphate substrates85US 7,026,461 B1Princeton University · 2006